Neurons expressing cholecystokinin B receptor (CCKBR), the major CCK receptor in the brain. CCKBR (also known as CCK-B or CCK2) is a G protein-coupled receptor (GPCR) belonging to the gastrin/cholecystokinin receptor family. In the brain, CCKBR is widely distributed and plays crucial roles in modulating anxiety, memory, pain perception, and appetite. CCKBR neurons represent a significant population of GABAergic interneurons in cortical and hippocampal regions, where they regulate neuronal excitability and circuit-level processing.
CCKBR-expressing neurons are found throughout the central nervous system with particularly high densities in:
- Hippocampus: CA1 and CA3 pyramidal layers, dentate gyrus hilus. CCKBR is highly expressed on basket cells and other GABAergic interneurons targeting pyramidal neuron somata.
- Cerebral Cortex: Layers II-III and V-VI, particularly in prefrontal, entorhinal, and piriform cortices.
- Amygdala: Central nucleus, basolateral complex, especially in intercalated cell masses.
- Hypothalamus: Paraventricular nucleus, suprachiasmatic nucleus, arcuate nucleus.
- Midbrain: Periaqueductal gray, dorsal raphe nucleus, substantia nigra pars compacta.
- Brainstem: Nucleus tractus solitarius, dorsal motor nucleus of the vagus.
The distribution pattern suggests CCKBR neurons play modulatory roles in limbic circuits, autonomic processing, and sensory integration.
CCKBR is a 447-amino acid GPCR that couples primarily to Gq/11 proteins, activating phospholipase C (PLC) signaling cascades:
- Ligands: Cholecystokinin (CCK-4, CCK-8, CCK-33), gastrin (at lower affinity)
- Signaling: PLCβ → IP3/DAG → Ca²⁺ mobilization and PKC activation
- Expression: CCKBR mRNA peaks during early development (P7-P14) and remains stable in adulthood
- Alternative splicing: Produces splice variants with altered G-protein coupling efficiency
- Dimerization: Can form homodimers and heterodimers with CCK-A receptors
CCKBR neurons exhibit distinct electrophysiological signatures:
- Resting membrane potential: -65 to -75 mV
- Input resistance: 150-300 MΩ (varies by brain region)
- Action potential duration: 0.8-1.5 ms
- Firing patterns: Predominantly fast-spiking and non-adapting in cortical regions
- Synaptic inputs: Dense excitatory input from pyramidal neurons; receives inhibitory input from other interneurons
- Synaptic outputs: Powerful perisomatic inhibition onto pyramidal neurons via GABA release
CCKBR neurons form inhibitory connections within local circuits:
- Cortical microcircuitry: CCKBR basket cells target pyramidal neuron somata and proximal dendrites
- Hippocampal circuitry: Mossy fiber-associated CCK cells modulate CA3 pyramidal neuron activity
- Amygdala networks: CCKBR interneurons in basolateral amygdala regulate fear circuitry
- Long-range projections: Some CCKBR neurons project to distant targets including thalamus and brainstem
CCKBR neurons are affected in Alzheimer's disease through multiple mechanisms:
- Amyloid-β impact: Aβ1-42 reduces CCKBR expression in hippocampal interneurons, disrupting GABAergic inhibition
- Tau pathology: CCKBR neurons show early tau accumulation in the entorhinal cortex
- Network dysfunction: Loss of CCK interneuron-mediated inhibition contributes to hippocampal hyper excitability and seizure activity in AD
- Cognitive correlates: CCKBR polymorphisms are associated with age-related cognitive decline
- Therapeutic potential: CCKBR agonists show promise in improving memory consolidation in animal models
- CCKBR expression is altered in the basal ganglia of PD patients
- CCKBR neurons in the substantia nigra pars reticulata may compensate for dopaminergic degeneration
- CCK-8 administration can reduce levodopa-induced dyskinesias via CCKBR activation
¶ Anxiety and Panic Disorders
- CCKBR is a key receptor in panic and anxiety circuitry
- CCK-4 (a CCKBR agonist) induces panic attacks in humans and rodents
- CCKBR antagonists (e.g., proglumide) have anxiolytic properties
- CCKBR polymorphisms are linked to panic disorder susceptibility
- CCKBR in periaqueductal gray and spinal cord modulates nociception
- CCKBR activation produces analgesic effects in inflammatory and neuropathic pain models
- Endogenous CCK acts as a tonic pain inhibitor
CCKBR represents a therapeutic target for:
- Anxiety and panic disorder: CCKBR antagonists as anxiolytics
- Alzheimer's disease: CCKBR agonists for cognitive enhancement
- Pain management: CCKBR-targeted analgesics
- Obesity: CCKBR involvement in satiety signaling
- Epilepsy: CCKBR modulation as anticonvulsant strategy
- Localization: In situ hybridization, immunohistochemistry for CCKBR
- Functional studies: Calcium imaging, electrophysiology in acute brain slices
- Genetic models: CCKBR knockout mice show increased anxiety and impaired memory
- Optogenetics: Channelrhodopsin expression under CCK promoter for circuit mapping
- CCK-B receptors in brain function and disease (2019)
- Cholecystokinin in Alzheimer's disease (2020)
- CCK receptor distribution in rat brain (2018)
- CCK and anxiety: translational approaches (2021)
- CCKBR interneurons in hippocampal oscillations (2019)
- Panic disorder and CCK system (2020)
- CCK in pain modulation (2018)
- CCKBR gene polymorphisms and neuropsychiatric disorders (2021)